In Brief: Mallinckrodt's Anexsia
Executive Summary
Mallinckrodt's Anexsia: Oral hydrocodone/acetaminophen product scheduled for introduction Sept. 1. The 10/660 mg dosage strength of hydrocodone/acetaminophen, which was approved July 29 to treat moderate to moderately severe pain, is the strongest available combination of the two analgesics, the company states. The applications for both UltraJect and Anexsia were filed June 30, 1995...